Skip to main content
PLOS One logoLink to PLOS One
. 2022 Jun 22;17(6):e0270158. doi: 10.1371/journal.pone.0270158

Preconception risk factors and health care needs of pregnancy-planning women and men with a lifetime history or current mental illness: A nationwide survey

Cindy-Lee Dennis 1,2,3,*, Hilary K Brown 4,5,6, Sarah Brennenstuhl 1, Simone Vigod 3,6, Ainsley Miller 7, Rita Amiel Castro 8, Flavia Casasanta Marini 2, Catherine Birken 9,10
Editor: Emily W Harville11
PMCID: PMC9216596  PMID: 35731809

Abstract

Objectives

While depression and anxiety are common in women and men of reproductive age, preconception interventions to optimize the health of individuals with mental illness before pregnancy is limited and focuses primarily on psychotropic medication management. Comparing individuals with depression, anxiety, and comorbidity to those with neither condition, we identified areas of preconception care optimization related to psychosocial risk factors, general physical health, medication use, and uptake of high-risk health behaviours. We also investigated differences in preconception health care use, attitudes, and knowledge.

Method

We conducted a nationwide survey of 621 women (n = 529) and men (n = 92) across Canada who were planning a pregnancy within five years, including those with lifetime or current depression (n = 38), anxiety (n = 55), and comorbidity (n = 104) and those without mental illness (n = 413). Individuals with depression, anxiety, and comorbidity were compared to individuals without mental illness using logistic regression, adjusted for age, sex, and education level.

Results

Individuals with a lifetime or current mental illness were significantly more likely to have several risk factors for suboptimal reproductive and perinatal outcomes, including increased rates of obesity, stress, fatigue, loneliness, number of chronic health conditions, and medication use. Further, they were more likely to have high-risk health behaviours including increased substance use, internet addiction, poorer eating habits, and decreased physical activity. By assessing depression, anxiety, or both separately, we also determined there was variation in risk factors by mental illness type.

Conclusion

Our nationwide study is one of the first and largest to examine the preconception care needs of women and men with a lifetime or current mental illness who are pregnancy-planning. We found this population has many important reproductive and perinatal risk factors that are modifiable via preconception interventions which could have a significant positive impact on their health trajectories and those of their future children.

Introduction

Preconception health among pregnancy-planning women and men has increasingly been shown to strongly influence reproductive, perinatal, and child outcomes [1]. Yet, many individuals of reproductive age are in poor health at conception, with ever-growing rates of obesity. Since nearly 50% of pregnancies in high-income countries are unplanned [2], risk factors for adverse perinatal outcomes such as poor physical health, medication use, and high-risk health behaviours are often only addressed at the initial prenatal appointment at the end of the critical first trimester [3]. Research into the Developmental Origins of Health and Disease (DOHaD) suggests harmful exposures that occur early in life, while tissues and organs are developing, increase the risk of disease later in life. The DOHaD evidence demonstrates an inextricable link between the in-utero environment and child risk of developing obesity, type 2 diabetes, insulin resistance, asthma, cardiovascular diseases, behavioural disorders, and many other non-communicable diseases [4]. Preconception care is paramount for reducing risk factors and promoting healthy behaviours so that diverse health outcomes can be optimized [5, 6]. While preconception care interventions have been developed for women at high risk for adverse perinatal outcomes, including those with diabetes or HIV [7, 8], minimal attention has focused on the preconception care needs of women and men with common mental illnesses such as depression and anxiety.

Depression and anxiety are major causes of disability worldwide [9]. Lifetime prevalence rates are 20% for depression and 30% for anxiety disorders [9], with higher rates in women than men [10]. Comorbidity is common, as 60% of individuals with anxiety disorders have also experienced a depressive episode [11]. Median age of onset is early in the reproductive years, with a high recurrence rate [9]. Importantly, mental illness in women diagnosed before pregnancy is associated with adverse reproductive and perinatal outcomes [12, 13]. Previous work has also found associations between perinatal mental illness and negative child outcomes, including obesity, asthma, behavioural disorders, mental illness, and many other non-communicable diseases [1417]. While depression and anxiety have been identified as important conditions in the context of preconception health [1821], recommendations primarily focus on the safety of pharmacologic treatments in pregnancy—not how to optimize health generally [22]. Preconception care for men with mental health problems is even more limited, primarily highlighting the impact of paternal depression on maternal depression risk and maternal-child interactions [23]. To inform the development of a comprehensive preconception care program that is acceptable, accessible, and scalable for both women and men with common mental health problems, an understanding of their unique preconception needs is required.

Objectives

The purpose of this nationwide study was to examine the preconception care needs of pregnancy-planning women and men with current or lifetime depression and/or anxiety. Comparing individuals with depression, anxiety, and comorbidity to those with neither condition, our first objective was to identify areas of preconception care optimization in: (1) psychosocial risk factors, (2) general physical health, (3) medication use, and (4) uptake of high-risk health behaviours. Our second objective was to investigate differences in preconception health care use, attitudes, and knowledge.

Method

Participants

This study was part of a large cross-sectional survey assessing the preconception care attitudes, beliefs, and intervention preferences of women and men across Canada, conducted in May and June 2019. The study was formative work for Healthy Life Trajectory Initiative (HeLTI) Canada [24]. Participants were recruited via social media, advertisements on provincial public health unit websites, identification of eligible individuals through pre-existing research databases, and referrals from ongoing cohort studies. Women and men were eligible for this study if they were planning to have children within the next five years, could read and understand English, and had access to the Internet. We limited our inclusion criteria to target individuals planning pregnancy in the next 5 years to be consistent with previous studies [25]. Individuals interested in participating received an introductory email after contacting the research team [25]. Written informed consent was obtained from all eligible participants using an online consent form in REDCap [26]; those who provided consent then completed a secure online questionnaire. Research assistants provided reminder follow-up telephone calls to promote completeness of data. Ethics approval was obtained by St. Michael’s Hospital (REB# 18–309) and the University of Alberta (REB# 000092107).

Measures

Depression and anxiety

Depression was assessed using two methods. Current depressive symptoms were identified using the Patient Health Questionnaire (PHQ-9) [27], a 9-item scale assessing symptoms in the last 2 weeks. Response options ranged from “not at all” (0) to “nearly every day” (3), with a total score calculated by summing the items. Scores >10 were considered moderate to severe depressive symptoms. This scale is valid and reliable in similar populations [28] and in our sample had a Cronbach’s alpha of .83. Lifetime depression was ascertained by, “Have you ever been diagnosed with depression?” Those who replied “yes” and/or scored >10 on the PHQ-9 were coded as positive for ever having depression.

Anxiety was also assessed using two methods. Current anxiety symptoms were identified using the Generalized Anxiety Disorder (GAD-7) [29], a 7-item scale assessing symptoms in the last 2 weeks. Response options ranged from “not at all” (0) to “nearly every day” (3) with a total score calculated by summing the items. A total score of >10 indicated significant anxiety symptoms. This scale is valid and reliable in similar populations [30] and had a Cronbach’s alpha of .89 in our sample. Lifetime anxiety was ascertained by, “Have you ever been diagnosed with anxiety?” Those who replied “yes” to this question and/or scored >10 on the GAD-7 were coded as positive for ever having anxiety. Those who were coded positive as ever having depression and anxiety were considered to have comorbid depression and anxiety.

Psychosocial risk factors

Three psychosocial risk factors were assessed: perceived stress, fatigue, and loneliness. Stress was measured using the Perceived Stress Scale (PSS) [31]. This 10-item scale asked about frequency of feelings in the past month using response options ranging from 0 to 4. A total score was calculated by summing the items, after reverse-coding four questions. Scores >26 were considered high perceived stress. This scale is valid and reliable in similar populations [32] and in our sample, had a Cronbach’s alpha of .87. Fatigue was assessed using, “How fatigued are you during the weekdays?” Response options ranged from “never fatigued” (1) to “almost always fatigued” (5), dichotomized to often or almost always fatigued. Loneliness was assessed using three validated items from the UCLA Loneliness Scale [33] assessing frequency of feeling lack of companionship, left out, and isolated from others. Response options range from “often” (1) to “hardly ever or never” (3). For each item, a binary variable was created that identified those who replied “often”.

General physical health

Participants were asked to report diagnosed chronic health conditions including: asthma, diabetes, hepatitis B and C, hypertension, inflammatory bowel disease, renal disease, rheumatoid arthritis and other autoimmune diseases, seizure disorders, systemic lupus erythematosus, and thyroid disease. As the prevalence for these conditions was very low (< 3% excluding asthma and thyroid disease), those with 1 or more chronic conditions were grouped. Self-rated health was measured by “How would you rate your overall health?” The response options were: “very healthy”, “healthy”, “OK”, and “unhealthy”, dichotomized to identify those who rated themselves as less than healthy (OK/unhealthy) and healthy (healthy/very healthy).

Medication use

Medication use was assessed by, “Do you currently use any of the following medications?” Responses were “yes” or “no” to: prescribed medications, over-the-counter medications, herbal or natural medications, weight-loss medications/supplements, and athletic products/supplements. The last two categories were combined due to the low number reporting use of weight-loss medications or supplements.

High-risk health behaviours

Eight health behaviours were assessed that may increase the risk of adverse reproductive and perinatal outcomes [34]: (1) frequent alcohol use, (2) any cigarette smoking, (3) cannabis use, (4) low physical activity level, (5) overweight and obesity, (6) poor eating habits, (7) internet addiction and (8) sleeping <6 hours/night. Internet addiction, while not previously identified as a risk factor, was included in an exploratory manner based on emerging evidence suggesting that higher level of device use is associated with maternal depression and poorer relationship satisfaction [35, 36]. Frequent alcohol use was defined as alcohol use more than three times per week, measured by “How often do you drink a beverage containing any alcohol?” taken from the PrimeScreen tool described below. Any cigarette smoking was derived from the following item created by the study team for this survey: “On a typical day, how many cigarettes do you smoke?” Occasional smoking was listed as a response category and included with daily smoking in the analysis. Cannabis use was defined as at least monthly use, derived from an item created by the study team for this survey, “In the past 12 months, have you used cannabis (marijuana) for non-medical/recreational reasons?” For those with a positive response, another question was asked about frequency of use which was used to classified as either used at least once in the past month vs. less. Low physical activity level was defined as obtaining <600 metabolic equivalents per week, based on the Global Physical Activity Questionnaire (GPAQ) [37]. Overweight and obesity were defined as having a BMI ≥25, based on self-reported weight and height. Poor eating habits were defined as having a total score <12 on the PrimeScreen tool, which contains 24 questions about dietary intake [38]. Internet addiction was defined as having a total score >30 on the Internet Addiction Test, which indicates at least a mild/moderate addiction [39]. Finally, sleeping <6 hours/night was based on, “How many hours of sleep do you usually get a night on a weekday/weekend?”

Preconception health care use, attitudes, and knowledge

Preconception health care use was measured by “Have you ever received preconception health care from a healthcare professional?” Response options were “yes” and “no”. General attitudes surrounding preconception care were measured using a question designed by the study team, “How important do you consider preconception health for the public, in general?” Responses ranged from “very important” (1) to “not important at all” (5). The variable was dichotomized to identify those with negative attitudes, defined having a score >3. Preconception health knowledge was assessed using the Preconception Health Knowledge Questionnaire (PHKQ), a 25-item multiple choice knowledge test that has been validated in this sample [40]. Responses were coded as being correct or incorrect, and a total score was calculated based on the number of correct responses.

Demographics

We also collected data on the demographic characteristics of the sample, including: age (in years), sex (women/men), household income (<$75,000, or ≥$75,000 CAD), education level (high school/college, or university degree), employment status (paid part- or full-time employment, or no paid employment [i.e., on parental leave, unemployed, student, or other]), being born in Canada (yes/no), ethnic origin, and having a child < 2 year of age (yes/no). As pregnancy loss and infertility are related to mental health [41, 42], we reported the proportion of sample that experienced miscarriage and used/were using fertility treatments.

Data analysis

Sample characteristics were summarized using means and standard deviations for continuous variables and frequencies and percentages for nominal variables and presented by mental illness status. Comparisons across groups were made using an omnibus test from a one-way ANOVA for age (which was approximately normally distributed); Chi square tests were used to compare the distributions of the other sample characteristics. To identify areas of preconception care optimization in individuals with lifetime or current depression, anxiety, and comorbidity, we calculated adjusted odds ratios (aOR) for each group for (1) psychosocial risk factors, (2) general physical health, (3) medication use, and (4) uptake of high-risk health behaviours using logistic regression, with those with neither condition serving as the comparison group. To investigate differences in preconception care use, attitudes, and knowledge, we used logistic regression to calculate aORs for prior use of preconception health care and negative preconception health attitudes, and Ordinary Least Squares regression to calculate the unit-change in preconception health knowledge for each of the comparisons. All models controlled for age, sex, and education level; adjustment variables were selected a priori. All analyses were undertaken using SPSS (v25). Statistical significance was established as p < .05. Missing data ranged from model to model, with a high of <10% in models of some health behaviours (e.g., sleep), preconception health knowledge, and attitudes about preconception care.

Results

Sample characteristics

Of the 611 pregnancy-planning participants with data on depression and anxiety, 38 (6.4%) had lifetime or current depression, 55 (9.0%) had lifetime or current anxiety, and 104 (17.0%) had lifetime or current depression and anxiety (comorbidity). The mean age of the sample was 32.9 years and ranged from 19 to 60. Women made up 85% of the sample. The majority had a European ethnic origin (72.6%) followed by an Asian ethnic origin (14.2%); other identified origins were reported in very small numbers. About a quarter of the sample had experienced pregnancy loss (26.8%) and just under 10% reported using fertility treatments (7.3%). Table 1 presents the sample demographic characteristics by mental illness status. Significant differences in the distribution of sex, education level, employment status, nativity and ethnic origin were found by mental health status (none, depression, anxiety and comorbidity).

Table 1. Characteristics of individuals with depression, anxiety, and comorbidity compared to those without mental illness.

No depression or anxiety Depression Anxiety Comorbidity
Variable (n = 413) (n = 39) (n = 55) (n = 104) P-value a
Age, mean (SD) 32.88 (4.16) 32.64 (4.46) 33 (5.23) 32.75 (4.37) .433
Female, n (%) 337 (82.2) 36 (92.3) 52 (94.5) 96 (92.3) .003
Household income < $75K CAD, n (%) 62 (15.0) 9 (23.1) 7 (12.7) 19 (18.3) .461
High school/college education, n (%) 88 (21.3) 12 (30.8) 12 (21.8) 38 (36.5) .009
No paid employment, n (%) 122 (29.5) 19 (48.7) 22 (40.0) 41 (39.4) .021
Born in Canada, n (%) 321 (77.7) 31 (79.5) 49 (89.1) 98 (94.2) < .001
European Ethnic Origin, n (%) 274 (70.1) 33 (89.2) 43 (81.1) 71 (70.3) .036
Youngest child < 2 years old, n (%) 135 (32.7) 15 (38.5) 21 (38.2) 47 (45.2) .113

a Derived from one-way ANOVA for continuous variables and Chi square tests for categorical variables.

Psychosocial factors

One-third of pregnancy-planning participants had high perceived stress (34.7%) and reported being often or almost always fatigued (34.6%); a significant number of participants also reported often lacking companionship (9.2%), feeling left out (8.2%), or feeling isolated (11.0%). Individuals who had depression, anxiety, or both compared to those with no mental illness were significantly more likely to have high perceived stress, fatigue, and loneliness (Table 2). For high perceived stress, the aORs ranged from 2.67 (aOR = 2.67; 95%CI 1.48–4.83) for anxiety to 8.34 (95%CI 5.06–13.74) for comorbidity. For fatigue, the aORs ranged from 2.08 (95%CI 1.12–3.86) for anxiety to 4.51 (95%CI 2.20–9.24) for depression. For the loneliness, the largest aORs were found for lack of companionship, with an aOR of 6.98 (95%CI 3.35–14.17) for comorbidity. For those with anxiety, the elevated aORs were consistently smaller in magnitude than for those with depression or comorbidity, and the aOR for lack of companionship was non-significant.

Table 2. Adjusted odds of psychosocial risk factors, general physical health indicators, medication use, and high-risk health behaviours among individuals with depression, anxiety, and comorbidity compared to those without mental illness a.

Depression Anxiety Comorbidity
Variable N Odds Ratio b 95% CI P-value Odds Ratio b 95% CI P-value Odds Ratio b 95% CI P-value
Psychosocial Risk Factors
High perceived stress 597 3.597 1.812 7.138 < .001 2.674 1.480 4.830 0.001 8.336 5.057 13.743 < .001
Fatigue 566 4.512 2.204 9.237 < .001 2.080 1.121 3.861 0.020 4.161 2.565 6.750 < .001
Often lacking companionship 601 3.770 1.544 9.206 0.004 1.231 0.407 3.725 0.712 3.227 1.665 6.255 0.001
Often feeling left out 601 4.444 1.574 12.546 0.005 3.270 1.186 9.015 0.022 6.894 3.354 14.168 < .001
Often feeling isolated 601 4.407 1.839 10.560 0.001 2.601 1.089 6.211 0.031 4.800 2.567 8.978 < .001
General Physical Health
≥ 1 chronic health conditions 611 1.391 0.648 2.986 0.397 1.392 0.719 2.693 0.326 2.536 1.579 4.074 < .001
Fair or poor self-rated health 611 1.819 0.878 3.767 0.107 1.574 0.823 3.009 0.170 2.441 1.517 3.929 < .001
Medication Use
Prescription medications 611 2.799 1.427 5.491 0.003 3.184 1.781 5.691 < .001 5.373 3.374 8.555 < .001
Over-the-counter medications 611 0.728 0.292 1.811 0.495 1.338 0.689 2.597 0.390 1.696 1.027 2.802 0.039
Herbal or natural medications 611 0.491 0.112 2.142 0.344 1.611 0.692 3.750 0.853 0.847 0.392 1.859 0.689
Weight-loss/athletic products 611 0.635 0.082 4.93 0.664 1.41 0.395 5.033 0.597 1.513 0.572 3.999 0.3404
High-Risk Health Behaviours
Frequent alcohol use 587 1.129 0.469 2.716 0.79 1.052 0.481 2.299 0.900 1.422 0.805 2.512 0.225
Any cigarette smoking 582 --c -- -- -- 0.969 0.271 3.459 0.961 1.161 0.491 2.745 0.733
Monthly cannabis use 611 0.333 0.044 2.526 0.287 1.338 0.488 3.668 0.572 2.10 1.061 4.150 0.033
Low physical activity level 577 0.836 0.420 1.666 0.611 1.134 0.627 2.052 0.677 0.930 0.589 1.469 0.755
Overweight or obesity 594 2.728 1.274 5.541 0.010 0.896 0.497 1.615 0.715 1.654 1.037 2.638 0.035
Poor eating habits 588 1.125 0.565 2.240 0.738 1.435 0.791 2.601 0.234 1.611 1.018 2.548 0.042
Internet addiction 568 1.173 0.530 2.598 0.694 2.086 1.091 3.989 0.026 1.731 1.044 2.869 0.033
Sleeping < 6 hours / night 566 1.739 0.670 4.514 0.256 0.890 0.299 2.649 0.835 1.468 0.741 2.908 0.271

a Current symptoms and/or lifetime diagnosis.

b Adjusted for age, sex, and education level.

c Could not be calculated due to the small number of individuals with depression who reported smoking.

General physical health

Nearly one-quarter of pregnancy-planning participants reported being diagnosed with one or more chronic conditions (23.5%) and rated themselves as being less than healthy (24.3%). Individuals with comorbidity compared to those without mental illness had more than twice the odds of having one or more chronic conditions (aOR 2.54, 95%CI 1.58–4.07) or poor perceived health (aOR 2.44, 95%CI 1.52–3.93) (Table 2). No differences were found for those with depression only or anxiety only compared to those without mental illness.

Medication use

Prescription medications were used by 33.0% of participants, over-the-counter medications by 20.8%, herbal or natural medications by 9.3%, and weight-loss/athletic products/supplements by 4.7%. Individuals who had depression, anxiety, or both compared to those without mental illness had significantly higher odds of prescription medication use (Table 2), ranging from an aOR of 2.80 (95%CI 1.43–5.9) for depression to 5.37 (95%CI 3.37–8.5) for comorbidity. Those with comorbidity also had significantly higher odds of over-the-counter medication use (aOR 1.70, 95%CI 1.03–2.80). No other findings were statistically significant.

High-risk health behaviours

The prevalence estimates of the high-risk health behaviours were 19.6% for frequent alcohol use, 6.0% for any cigarette smoking, 8.5% for cannabis use, 44.0% for low physical activity level, 54.4% for overweight and obesity, 44.7% for poor eating habits, 24.3% for Internet addiction, and 10.6% for sleeping <6 hours/night. Individuals who had comorbidity, compared to those with no mental illness, were more likely to use cannabis (aOR 2.10, 95%CI 1.06–4.15), be overweight or obese (aOR 1.65, 95%CI 1.04–2.64), have poor eating habits (aOR 1.61, 95%CI 1.02–2.55), and have internet addiction (aOR 1.73, 95%CI 1.04–2.87). Those with depression only were more likely to be overweight or obese (aOR 2.73, 95%CI 1.27–5.84), while those with anxiety only were more likely to have an internet addiction (aOR 2.09, 95%CI 1.09–3.99) (Table 2). No other differences were statistically significant.

Preconception health care use, attitudes, and knowledge

Two-thirds of participants had not previously received preconception care (66.3%) and one in five considered preconception care to be unimportant (19.3%). The mean number of correct responses on the Preconception Health Knowledge Test was 15.8 (63%) out of 25. Individuals who had comorbidity were more likely to have received preconception care than those without mental illness (aOR 1.61, 95%CI 1.02–2.54) (Table 3). There were no differences across groups in preconception care attitudes. When looking at preconception health knowledge, those with comorbidity had significantly higher knowledge test scores (on average 1.6 points) compared to those without a mental illness. To explain this finding, we examined each question separately to determine which questions were answered correctly by a greater number of those with comorbidity. A greater proportion of those with comorbidity answered questions correctly on when to see a health care provider after thinking about getting pregnant, intimate partner violence, and what environmental exposures to limit.

Table 3. Preconception health care use, attitudes, and knowledge among individuals with depression, anxiety, and comorbidity compared to those without mental illness a.

Depression Anxiety Comorbidity
Variable N Odds Ratio b 95% CI P-value Odds Ratio b 95% CI P-value Odds Ratio b 95% CI P-value
Ever used preconception health care 611 0.665 0.310 1.424 0.293 0.794 0.447 1.475 0.465 1.608 1.018 2.539 0.042
Consider preconception care less than important 561 1.058 0.437 2.565 0.900 1.133 0.514 2.498 0.756 0.956 0.520 1.755 0.883
Variable N β b 95% CI P-value β b 95% CI P-value β b 95% CI P-value
Preconception health knowledge 563 0.705 -0.640 2.049 0.304 1.033 -0.159 2.225 0.089 1.607 0.703 2.511 0.001

a Current symptoms and/or lifetime diagnosis.

b Adjusted for age, sex, and education level.

Discussion

Our nationwide study is one of the first and largest to examine the preconception care needs of women and men with a lifetime or current mental illness who are pregnancy-planning. Our results clearly suggest that individuals with a mental illness were significantly more likely to have several important risk factors that lead to suboptimal reproductive and perinatal outcomes [1, 34], including increased stress, fatigue, loneliness, number of chronic health conditions, and medication use. Further, they were more likely to have high-risk health behaviours including poorer eating habits, decreased physical activity, increased substance use, and internet addiction. Importantly, those with a mental illness were significantly more likely to be overweight and obese, a factor related to numerous negative health outcomes to both women and their children [43]. By assessing the preconception health optimization needs of those with depression, anxiety, or both separately, we were also able to determine if there was any variation by mental illness type. We found that, in some cases, needs could be specific to a particular mental illness profile. For example, only comorbidity was associated with certain preconception health risk factors such as poor physical health, over-the-counter medication use, cannabis use, and poor eating habits, whereas high perceived stress, fatigue, and loneliness were found consistently for all mental illness types. Taken together, these findings suggest tailoring interventions by mental illness type might be useful, but that all categories of care optimization should be considered in preconception health care planning for individuals with mental illness.

It is encouraging that attitudes about preconception care did not differ between those with any of the mental health outcomes and those without. This suggests that individuals with a mental health problem may be receptive to engaging with preconception health care services. We found that individuals with comorbidity were more likely to have previously used preconception care compared to those without mental illness. It is possible that due to the complexity of their mental health problems, individuals with comorbidity have more frequent access to the health care system and consequently greater opportunity to receive preconception health care counselling. Perhaps related to this was the unexpected finding that women and men with comorbidity had greater preconception health knowledge than those without mental illness. However, this was not explained by knowledge about mental illness and pregnancy specifically. The reasons for this finding are unclear, but it is speculated that persons with mental illness may already be targeted in the health care system for preconception health care counseling. However, knowledge does not necessarily translate into behaviour change [44], so interventions to improve preconception health should include more than information. To clinically improve reproductive and perinatal outcomes of pregnancy-planning individuals with mental health problems, work with individuals must be conducted in parallel with population-level efforts, including policies that support mental health.

Our finding that women, those with lower education, and those unemployed were overrepresented among individuals with depression, anxiety, and comorbidity is consistent with research demonstrating social disparities in the prevalence of mental health problems [45, 46]. Our finding of socioeconomic differences between people with and without lifetime or current mental health problems demonstrates that preconception care for individuals with depression and/or anxiety should recognize socioeconomic barriers to preconception care access as well as address these social factors and how they impact reproductive and perinatal health through the tailoring of preconception health care content.

Our findings add to the limited research on preconception health care for individuals with mental health problems. Research to date has focused primarily on preconception care in women, with an emphasis on mental illness screening and psychotropic medication counseling [1821]. However, research has not addressed the broader preconception health needs of women with pre-existing depression and/or anxiety. Preconception care is not routinely offered to men, and recommendations that exist for men with mental health problems only touch on the impact of paternal depression on maternal depression risk and on the quality of maternal-child interactions [23]. The inclusion of men in our sample is a significant strength, given the growing body of literature demonstrating the contribution of paternal preconception risk factors to reproductive and perinatal outcomes [47]. Further, while the number of men was small compared to women (which did not allow for stratified analysis), we were able to calculate sex-adjusted estimates that can be used to guide future research focused on men specifically. Our results suggest several areas for preconception health optimization in pregnancy-planning women and men with mental health problems, and particularly those with comorbidity, including screening for and addressing risk factors related to psychosocial wellbeing, physical health, medication use, and high-risk health behaviours. These data demonstrate the need for preconception health interventions targeting the broad psychosocial, physical, and behavioural wellbeing of individuals with mental health problems, and not only management of their psychotropic medications.

Limitations

Limitations include the small proportion of men and those without children. Future research should use more diverse samples, including more men and nulliparous individuals, to replicate these findings. While individuals were recruited, not couples, it is possible that both members of a couple participated in the study. Due to the small proportion of men (and therefore low potential for heterosexual couples) and no one identifying as a same-sex couple, we do not believe this would have affected the model estimation. We did not have information on response rate, as this was an online survey; we only had the number of completed responses. Another limitation is the lack of objective measures of chronic health conditions, medication use, and health behaviours, with data collected through a cross-sectional, self-reported survey. It is possible that the current mental state of participants affected their subjective responses, resulting in stronger associations than would be found if using more objective measures, such as medical records. Related to this, the measures used to ascertain depression and anxiety can only capture symptoms or subjective recall of a diagnosis and not an actual diagnosis. Thus, a limitation of the work is that diagnostic interviews did not confirm lifetime or current mental health status.

Conclusion

The results of our nationwide survey of pregnancy-planning women and men in Canada suggest that ever having depression, anxiety, or both is associated with a higher likelihood to have increased perceived stress, fatigue, loneliness, chronic health conditions, prescription medication use, and high-risk health behaviours, all of which are associated with suboptimal reproductive and perinatal outcomes [1, 34]. These data provide evidence of the preconception health management needs of individuals with mental health problems. Given that the risk factors examined herein are modifiable, preconception intervention on these factors could have a significant positive impact on the reproductive and perinatal outcomes of women and men with mental health problems and the wellbeing of their children.

Supporting information

S1 Dataset

(XLS)

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

This work was supported by the Canadian Institutes for Health Research (grant # HLC-154502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.World Health Organization. Preconception care: Maximizing the gains for maternal and child health. Geneva; 2013. Available: https://www.who.int/publications/i/item/WHO-FWC-MCA-13.02 [Google Scholar]
  • 2.Finer LB, Zolna MR. Unintended pregnancy in the United States: Incidence and disparities, 2006. Contraception. 2011;84: 478–485. doi: 10.1016/j.contraception.2011.07.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Moos M-K, Dunlop AL, Jack BW, Nelson L, Coonrod D V, Long R, et al. Healthier women, healthier reproductive outcomes: recommendations for the routine care of all women of reproductive age. Am J Obstet Gynecol. 2008;199: S280—9. doi: 10.1016/j.ajog.2008.08.060 [DOI] [PubMed] [Google Scholar]
  • 4.Baird J, Jacob C, Barker M, Fall C, Hanson M, Harvey N, et al. Developmental Origins of Health and Disease: A Lifecourse Approach to the Prevention of Non-Communicable Diseases. Healthcare. 2017;5. doi: 10.3390/healthcare5010014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Brown HK, Mueller M, Edwards S, Mill C, Enders J, Graves L, et al. Preconception health interventions delivered in public health and community settings: A systematic review. Can J Public Heal. 2017;108: e388—e397. doi: 10.17269/cjph.108.6029 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Hussein N, Kai J, Qureshi N. The effects of preconception interventions on improving reproductive health and pregnancy outcomes in primary care: A systematic review. Eur J Gen Pract. 2016;22: 42–52. doi: 10.3109/13814788.2015.1099039 [DOI] [PubMed] [Google Scholar]
  • 7.Herman WH, Janz NK, Becker MP, Charron-Prochownik D. Diabetes and pregnancy. Preconception care, pregnancy outcomes, resource utilization and costs. J Reprod Med. 1999;44: 33–38. [PubMed] [Google Scholar]
  • 8.Steiner RJ, Dariotis JK, Anderson JR, Finocchario-Kessler S. Preconception care for people living with HIV: recommendations for advancing implementation. AIDS. 2013;27 Suppl 1: S113—9. doi: 10.1097/QAD.0000000000000059 [DOI] [PubMed] [Google Scholar]
  • 9.Kessler RC, Angermeyer M, Anthony JC, DE Graaf R, Demyttenaere K, Gasquet I, et al. Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization’s World Mental Health Survey Initiative. World Psychiatry. 2007;6: 168–176. [PMC free article] [PubMed] [Google Scholar]
  • 10.Altemus M, Sarvaiya N, Neill Epperson C. Sex differences in anxiety and depression clinical perspectives. Front Neuroendocrinol. 2014;35: 320–330. doi: 10.1016/j.yfrne.2014.05.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Lamers F, van Oppen P, Comijs HC, Smit JH, Spinhoven P, van Balkom AJLM, et al. Comorbidity patterns of anxiety and depressive disorders in a large cohort study: the Netherlands Study of Depression and Anxiety (NESDA). J Clin Psychiatry. 2011;72: 341–348. doi: 10.4088/JCP.10m06176blu [DOI] [PubMed] [Google Scholar]
  • 12.Hoirisch-Clapauch S, Brenner B, Nardi AE. Adverse obstetric and neonatal outcomes in women with mental disorders. Thromb Res. 2015;135 Suppl: S60—3. doi: 10.1016/S0049-3848(15)50446-5 [DOI] [PubMed] [Google Scholar]
  • 13.Thombre MK, Talge NM, Holzman C. Association between pre-pregnancy depression/anxiety symptoms and hypertensive disorders of pregnancy. J Womens Health (Larchmt). 2015;24: 228–236. doi: 10.1089/jwh.2014.4902 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Brand SR, Brennan PA. Impact of antenatal and postpartum maternal mental illness: how are the children? Clin Obstet Gynecol. 2009/08/08. 2009;52: 441–455. doi: 10.1097/GRF.0b013e3181b52930 [DOI] [PubMed] [Google Scholar]
  • 15.Pierce M, Hope HF, Kolade A, Gellatly J, Osam CS, Perchard R, et al. Effects of parental mental illness on children’s physical health: Systematic review and meta-analysis. Br J Psychiatry. 2020;217: 354–363. doi: 10.1192/bjp.2019.216 [DOI] [PubMed] [Google Scholar]
  • 16.Hammen C, Brennan PA. Severity, Chronicity, and Timing of Maternal Depression and Risk for Adolescent Offspring Diagnoses in a Community Sample. Arch Gen Psychiatry. 2003;60: 253–258. doi: 10.1001/archpsyc.60.3.253 [DOI] [PubMed] [Google Scholar]
  • 17.Elgar FJ, McGrath PJ, Waschbusch DA, Stewart SH, Curtis LJ. Mutual influences on maternal depression and child adjustment problems. Clin Psychol Rev. 2004;24: 441–459. doi: 10.1016/j.cpr.2004.02.002 [DOI] [PubMed] [Google Scholar]
  • 18.Atrash HK, Johnson K, Adams M, Cordero JF, Howse J. Preconception care for improving perinatal outcomes: The time to act. Matern Child Health J. 2006;10: 3–11. doi: 10.1007/s10995-006-0100-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Connor KA, Cheng D, Strobino D, Minkovitz CS. Preconception Health Promotion Among Maryland Women. Matern Child Health J. 2014;18: 2437–2445. doi: 10.1007/s10995-014-1482-3 [DOI] [PubMed] [Google Scholar]
  • 20.Lassi ZS, Imam AM, Dean S V, Bhutta ZA. Preconception care: screening and management of chronic disease and promoting psychological health. Reprod Health. 2014;11 Suppl 3: S5. doi: 10.1186/1742-4755-11-S3-S5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Nypaver C, Arbour M, Niederegger E. Preconception Care: Improving the Health of Women and Families. J Midwifery Womens Health. 2016;61: 356–364. doi: 10.1111/jmwh.12465 [DOI] [PubMed] [Google Scholar]
  • 22.Frieder A, Dunlop AL, Culpepper L, Bernstein PS. The clinical content of preconception care: women with psychiatric conditions. Am J Obstet Gynecol. 2008;199. doi: 10.1016/j.ajog.2008.09.001 [DOI] [PubMed] [Google Scholar]
  • 23.Frey KA, Navarro SM, Kotelchuck M, Lu MC. The clinical content of preconception care: preconception care for men. Am J Obstet Gynecol. 2008;199. doi: 10.1016/j.ajog.2008.10.024 [DOI] [PubMed] [Google Scholar]
  • 24.Dennis CL, Marini F, Dick JA, Atkinson S, Barrett J, Bell R, et al. Protocol for a randomised trial evaluating a preconception-early childhood telephone-based intervention with tailored e-health resources for women and their partners to optimise growth and development among children in Canada: a Healthy Life Trajectory In. BMJ Open. 2021;11: 1–12. doi: 10.1136/bmjopen-2020-046311 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Chivers BR, Boyle JA, Lang AY, Teede HJ, Moran LJ, Harrison CL. Preconception health and lifestyle behaviours of women planning a pregnancy: A cross-sectional study. J Clin Med. 2020;9. doi: 10.3390/jcm9061701 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)–A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42: 377–81. doi: 10.1016/j.jbi.2008.08.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Kroenke Spitzer RL. The PHQ-9: A New Depression Diagnostic and Severity Measure. Psychiatr Ann. 2002;32: 509–515. doi: 10.3928/0048-5713-20020901-06 [DOI] [Google Scholar]
  • 28.Kocalevent R-D, Hinz A, Brähler E. Standardization of the depression screener patient health questionnaire (PHQ-9) in the general population. Gen Hosp Psychiatry. 2013;35: 551–555. doi: 10.1016/j.genhosppsych.2013.04.006 [DOI] [PubMed] [Google Scholar]
  • 29.Spitzer R, Kroenke K, Williams J, Lowe B. A brief measure for assessing generalized anxiety disorder. Arch Inern Med. 2006;166: 1092–1097. doi: 10.1001/archinte.166.10.1092 [DOI] [PubMed] [Google Scholar]
  • 30.Löwe B, Decker O, Müller S, Brähler E, Schellberg D, Herzog W, et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care. 2008;46: 266–274. doi: 10.1097/MLR.0b013e318160d093 [DOI] [PubMed] [Google Scholar]
  • 31.Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24: 385–396. doi: 10.2307/2136404 [DOI] [PubMed] [Google Scholar]
  • 32.Fliege H, Rose M, Arck P, Walter OB, Kocalevent RD, Weber C, et al. The Perceived Stress Questionnaire (PSQ) reconsidered: Validation and reference values from different clinical and healthy adult samples. Psychosom Med. 2005;67: 78–88. doi: 10.1097/01.psy.0000151491.80178.78 [DOI] [PubMed] [Google Scholar]
  • 33.Russell D. UCLA Lonliness Scale (Version 3): Realiability, Validity, and Factor Structure. J Pers Assess. 1996;66: 20–40. doi: 10.1207/s15327752jpa6601_2 [DOI] [PubMed] [Google Scholar]
  • 34.Robbins CL, Zapata LB, Farr SL, Kroelinger CD, Morrow B, Ahluwalia I, et al. Core state preconception health indicators—pregnancy risk assessment monitoring system and behavioral risk factor surveillance system, 2009. MMWR Surveill Summ. 2014;63: 1–62. [PubMed] [Google Scholar]
  • 35.McDaniel BT, Coyne SM. Technology interference in the parenting of young children: Implications for mothers’ perceptions of coparenting. Soc Sci J. 2016;53: 435–443. doi: 10.1016/j.soscij.2016.04.010 [DOI] [Google Scholar]
  • 36.Dennis CL, Carsley S, Brennenstuhl S, Brown HK, Marini F, Bell RC, et al. Screen use and internet addiction among parents of young children: A nationwide Canadian cross-sectional survey. PLoS One. 2022;17: 1–13. doi: 10.1371/journal.pone.0257831 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Armstrong T, Bull F. Development of the World Health Organization Global Physical Activity Questionnaire (GPAQ). J Public Health (Bangkok). 2006;14: 66–70. doi: 10.1007/s10389-006-0024-x [DOI] [Google Scholar]
  • 38.Rifas-Shiman SL, Willett WC, Lobb R, Kotch J, Dart C, Gillman MW. PrimeScreen, a brief dietary screening tool: reproducibility and comparability with both a longer food frequency questionnaire and biomarkers. Public Health Nutr. 2001;4: 249–254. doi: 10.1079/phn200061 [DOI] [PubMed] [Google Scholar]
  • 39.Young KS. Internet Addiction Test Online. Wood Dale, IL: Stoelting; 2009. Available: http://www.netaddiction.com/index.php?option=com_bfquiz&view=onepage&catid=46&Itemid=106 [Google Scholar]
  • 40.Cairncross Z, Dennis CL, Brennenstuhl S, Ravindran S, Enders J, Graves L, et al. Development and Psychometric Evaluation of the Preconception Health Knowledge Questionnaire. Am J Heal Promot. 2021;35: 172–178. doi: 10.1177/0890117120946682 [DOI] [PubMed] [Google Scholar]
  • 41.Farren J, Mitchell-Jones N, Verbakel JY, Timmerman D, Jalmbrant M, Bourne T. The psychological impact of early pregnancy loss. Hum Reprod Update. 2018;24: 731–749. doi: 10.1093/humupd/dmy025 [DOI] [PubMed] [Google Scholar]
  • 42.Chachamovich JR, Chachamovich E, Ezer H, Fleck MP, Knauth D, Passos EP. Investigating quality of life and health-related quality of life in infertility: A systematic review. J Psychosom Obstet Gynecol. 2010;31: 101–110. doi: 10.3109/0167482X.2010.481337 [DOI] [PubMed] [Google Scholar]
  • 43.Sanchez CE, Barry C, Sabhlok A, Russell K, Majors A, Kollins SH, et al. Maternal pre-pregnancy obesity and child neurodevelopmental outcomes: a meta-analysis. Obes Rev. 2018;19: 464–484. doi: 10.1111/obr.12643 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Prochaska JO, Redding CA, Evers KE. The transtheoretical model and stages of change. Health behavior: Theory, research, and practice, 5th ed. Hoboken, NJ, US: Jossey-Bass/Wiley; 2015. pp. 125–148. [Google Scholar]
  • 45.Belle D, Doucet J. Poverty, inequality, and discrimination as sources of depression among U.S. women. Psychol Women Q. 2003;27: 101–113. doi: 10.1111/1471-6402.00090 [DOI] [Google Scholar]
  • 46.Murali V, Oyebode F. Poverty, social inequality and mental health. Adv Psychiatr Treat. 2018/01/02. 2004;10: 216–224. doi: 10.1192/apt.10.3.216 [DOI] [Google Scholar]
  • 47.Khandwala YS, Baker VL, Shaw GM, Stevenson DK, Lu Y, Eisenberg ML. Association of paternal age with perinatal outcomes between 2007 and 2016 in the United States: population based cohort study. BMJ. 2018;363: k4372. doi: 10.1136/bmj.k4372 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Emily W Harville

24 Feb 2022

PONE-D-22-04073Preconception risk factors and health care needs of pregnancy-planning women and men with a lifetime history or current mental illness: A nationwide surveyPLOS ONE

Dear Dr. Dennis,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

The reviewers concur in regarding this as an interesting and important topic.  Please address the concerns about explaining the analysis details, and respond to the requests for additional analysis to the extent possible.​

==============================

Please submit your revised manuscript by Apr 10 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Emily W. Harville

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

"Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Pg 3, line 33 “preconception care use” is there a word missing here? Not sure what that is.

Pg 5, line 66 there needs a space between “optimized” and in-text citations

Pg 5, I understand the key of this manuscript is to link mental illness and adverse pregnancy outcomes but the first paragraph and the entire introduction focuses on those adverse pregnancy outcomes but leaves a bit to be desired about the focus at hand which is depression/anxiety. I would suggest possibly reframing to make the issue the mental illness and how it relates to other behaviors/medical outcomes

Pg 7, line 101 Could you please explain why the study team chose planning to have children within the next three year as an inclusion criteria. Why three years specifically?

Pg 9, lines 154-159 The questions asked for alcohol, cigarette, and cannabis use, where these taken from other surveys or were these study team created?

Pg 9, line 154 What is the rationale for including internet addiction? I haven’t seen this related to reproductive and perinatal outcomes and am interested in the rational. I reviewed the reference provided for the behaviors and didn’t see internet addiction included in that report so just interested in understanding the link.

Pg 10 lines 169-172 Why only use one question about attitudes? Where did this question come from? Seems that this is pretty important to only rely on one question.

Pg 11 line 204 Could you please provide an actual range distribution for the ages, especially since the lowest mean age is 32.64.

Pg 11 lines 204-206 I think this sentence needs to be worded better. I also think this may be super inflated. The sample sizes are so different so it would make sense.

Table 1 missing the decimal point for “67.9” for Household income for No depression or anxiety

Did you examine any gender differences? I know a major limitation was the lack of having men in your sample…would it make it cleaner to just remove the data from the men?

Also, were these supposed to be couples? Or are the men completely separate from each woman?

Reviewer #2: Authors do not provide enough information to determine if correct statistical analysis was utilized.

Comments for authors

Overall very interesting topic and more data and information is needed on the preconception counseling, support and interventions. Several Comments and suggestions

Line 34 in abstract – I would specifically list the number of women and men

Line 97 – define HeLTI (first use)

Methods

1) Authors do not comment on a survey response rate, this is a key method to a survey study and would recommend including in revisions

2) Authors commend on the Cronbach’s alpha for each survey which is more like a result. I would describe the Cronbach in statistical methods and then place the value in results

3) Line 144 – authors dichotomize to rated themselves as less that healthy – authors should clarify if very healthy, healthy, and ok are considered healthy and unhealthy is considered less than healthy

4) Line 156 – authors define any cigarette smoking by “On a typical day, how many cigarettes do you smoke?”, however a passive smoker that smokes once per week may list 0 – did the survey ask about intermittent smoking and quantify this. Authors should define it as daily smokers, versus intermittent, vs. none

5) Line 157 – again the definition of monthly cannabis seems like assumptions are being made if the questions is in the past 12 months have you used cannabis yes/no someone used it once and answered yes I am not sure I would consider this a monthly user – needs to clarify or define groupings better

6) In data analysis – for ANOVA describe decision making for using one way ANOVA, was normality determined to indicate this is the correct test, in addition what post-hoc analysis test was used to determine significance.

Results

7) Lines 206- 211 include p values for the findings

8) Overall – in all sections authors tend to refer to the table and then just repeat the results in the section. I would suggest so that readers can follow the results better to write is as a summary

Example: Patients with anxiety were more likely to have increased perceived stress (OR, CL); fatigue (OR/CI), feel left out, feel isolated but did not lack companionship. The refer to table for results

9) I know the numbers are small, but I think it would be interesting to stratify by women and men and report the results – many studies don’t include men for preconception evaluation, and I think authors should report what they found on this subset more than what is currently in the paper

General comments

10) Does the survey collect any data on infertility diagnosis or pregnancies failures, were they excluded this is not clear? An infertile couple maybe planning pregnancy in the next 3 years, but mental health may have been affected by unsuccessful attempts at pregnancy. If this information was not collected, I would list as a limitation.

11) Racial breakdown was not included, and I think very important to include as many of the outcomes assessed in this study have racial disparities. If not collected need to list as a limitation.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Abigail M. Pauley

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Jun 22;17(6):e0270158. doi: 10.1371/journal.pone.0270158.r002

Author response to Decision Letter 0


1 Apr 2022

Thank you for the opportunity to respond to reviewers’ comments. We have outlined how we have addressed their concerns, which we believe strengthens the manuscript.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Response: We will upload the dataset as requested.

Reviewer #1:

Pg 3, line 33 “preconception care use” is there a word missing here? Not sure what that is.

Response: We have added the word health care use to clarify.

Pg 5, line 66 there needs a space between “optimized” and in-text citations

Response: A space has been added.

Pg 5, I understand the key of this manuscript is to link mental illness and adverse pregnancy outcomes but the first paragraph and the entire introduction focuses on those adverse pregnancy outcomes but leaves a bit to be desired about the focus at hand which is depression/anxiety. I would suggest possibly reframing to make the issue the mental illness and how it relates to other behaviors/medical outcomes

Response: We have further clarified that there is a link between perinatal mental illness various child outcomes: “Previous work has found also associations between perinatal mental health and negative child outcomes, including obesity, asthma, behavioural disorders, mental health illness, and many other non-communicable diseases [14–17].”

Pg 7, line 101 Could you please explain why the study team chose planning to have children within the next three year as an inclusion criteria. Why three years specifically?

Response: We have clarified that “We limited our inclusion criteria to target individuals planning a pregnancy in the next 5 years to be consistent with previous studies [21].”

Pg 9, lines 154-159 The questions asked for alcohol, cigarette, and cannabis use, where these taken from other surveys or were these study team created?

Response: We have clarified in the measures section that the latter two questions were created by the study team and the former was taken from the PRIMEScreen tool.

Pg 9, line 154 What is the rationale for including internet addiction? I haven’t seen this related to reproductive and perinatal outcomes and am interested in the rational. I reviewed the reference provided for the behaviors and didn’t see internet addiction included in that report so just interested in understanding the link.

Response: We included internet addiction in an exploratory manner based on emerging evidence that it is associated with maternal depression and poorer relationship satisfaction. We now include this rationale in the measures section.

Pg 10 lines 169-172 Why only use one question about attitudes? Where did this question come from? Seems that this is pretty important to only rely on one question.

Response: Unfortunately, we only used this general question to investigate attitudes. The question was created by the study team. This is now indicated in the measures section.

Pg 11 line 204 Could you please provide an actual range distribution for the ages, especially since the lowest mean age is 32.64.

Response: We have provided the mean age for the overall sample and the range, which is large at 19 to 60. Note that the 60-year old is a father.

Pg 11 lines 204-206 I think this sentence needs to be worded better. I also think this may be super inflated. The sample sizes are so different so it would make sense.

Response: We have reworded the section identified.

Table 1 missing the decimal point for “67.9” for Household income for No depression or anxiety

Response: We have added the missing decimal point.

Did you examine any gender differences? I know a major limitation was the lack of having men in your sample…would it make it cleaner to just remove the data from the men?

Response: We were unable to examine gender differences due to the small numbers of men as you mentioned. We considered removing the men to provide a cleaner analysis. However, this would further obfuscate of preconception needs of men. By including them in the analysis, not only do we draw attention to the importance of studying men in the context of preconception health, but we can, at very least, provide sex-adjusted estimates that can be used to inform future research focused on men. We have provided more justification for including men despite their small numbers in the discussion.

Also, were these supposed to be couples? Or are the men completely separate from each woman?

Response: It is possible that some were couples, but this was not intended by the design. We are unable to decern how many were couples, but due to the small proportion of men (and therefore low potential for heterosexual couples) and no one identifying as a same-sex couple, we do not believe this would have impacted the model estimation. That said, we have added this concern to the limitations section.

Reviewer #2:

Overall very interesting topic and more data and information is needed on the preconception counseling, support and interventions. Several Comments and suggestions

Line 34 in abstract – I would specifically list the number of women and men

Response: This has been added as requested.

Line 97 – define HeLTI (first use)

Response: This has been added.

Methods

1) Authors do not comment on a survey response rate, this is a key method to a survey study and would recommend including in revisions

Response: Unfortunately, we do not have this data as this was an online survey. We only have the number of completed responses.

2) Authors commend on the Cronbach’s alpha for each survey which is more like a result. I would describe the Cronbach in statistical methods and then place the value in results

Response: Thank you for this suggestion. Since it was not an objective of the study to test the internal consistency of the measures, we consider the reported alphas to be characteristics of the measures themselves and not results of the study.

3) Line 144 – authors dichotomize to rated themselves as less that healthy – authors should clarify if very healthy, healthy, and ok are considered healthy and unhealthy is considered less than healthy

Response: We have clarified that it was spilt into two: healthy (OK/unhealthy) and healthy (healthy/very healthy).

4) Line 156 – authors define any cigarette smoking by “On a typical day, how many cigarettes do you smoke?”, however a passive smoker that smokes once per week may list 0 – did the survey ask about intermittent smoking and quantify this. Authors should define it as daily smokers, versus intermittent, vs. none

Response: We have clarified that the two groups were any cigarette smoking (daily or occasional) vs. none. Intermittent smoking would have been captured in occasional smoking.

5) Line 157 – again the definition of monthly cannabis seems like assumptions are being made if the questions is in the past 12 months have you used cannabis yes/no someone used it once and answered yes I am not sure I would consider this a monthly user – needs to clarify or define groupings better

Response: We have clarified that “For those with a positive response, another question was asked about frequency of use which was used to classified as either used at least once in the past month vs less.”

6) In data analysis – for ANOVA describe decision making for using one way ANOVA, was normality determined to indicate this is the correct test, in addition what post-hoc analysis test was used to determine significance.

Response: ANOVA was only used for the sample description and only for the variable of age, which was approximately normally distributed. No post hoc tests were undertaken; the p value is from the omnibus test. We have now included these details in the text.

Results

7) Lines 206- 211 include p values for the findings

Response: We have rewritten this section to address another Reviewer’s comment. And, to address your own comment below, we have simplified it greatly and no longer provide specific findings.

8) Overall – in all sections authors tend to refer to the table and then just repeat the results in the section. I would suggest so that readers can follow the results better to write is as a summary. Example: Patients with anxiety were more likely to have increased perceived stress (OR, CL); fatigue (OR/CI), feel left out, feel isolated but did not lack companionship. The refer to table for results

Response: We have simplified the results when appropriate.

9) I know the numbers are small, but I think it would be interesting to stratify by women and men and report the results – many studies don’t include men for preconception evaluation, and I think authors should report what they found on this subset more than what is currently in the paper

Response: Unfortunately, stratification was not possible due to the small numbers of men with any of the mental health outcomes.

General comments

10) Does the survey collect any data on infertility diagnosis or pregnancies failures, were they excluded this is not clear? An infertile couple maybe planning pregnancy in the next 3 years, but mental health may have been affected by unsuccessful attempts at pregnancy. If this information was not collected, I would list as a limitation.

Response: Women were included if they were planning for a pregnancy in the next 5 years. Women using fertility treatments and those who had experienced pregnancy loss were not excluded. We now report the proportion of the sample that reported having a miscarriage and using fertility treatments.

11) Racial breakdown was not included, and I think very important to include as many of the outcomes assessed in this study have racial disparities. If not collected need to list as a limitation.

Response: We did not collect data on race, but now include data on ethnic origin.

Attachment

Submitted filename: Formative Man4- mental health - Response- Mar 28 2022.docx

Decision Letter 1

Emily W Harville

9 May 2022

PONE-D-22-04073R1Preconception risk factors and health care needs of pregnancy-planning women and men with a lifetime history or current mental illness: A nationwide surveyPLOS ONE

Dear Dr. Dennis,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jun 23 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Emily W. Harville

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

Please address reviewer 2's minor points.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I greatly appreciate the author's responses and care in addressing them all in the manuscript or within the author replies.

Reviewer #2: Many comments in initial review were addressed

1) Response rate was not addressed because collection methods did not allow for this data collection, this should be added to a limitations of the study

2) Table 2 is very busy with lots of data - I would move the headings to the center and highlight each subsection to make following the data easier for readers

3) Line 376 has inaccurate punctuation

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Jun 22;17(6):e0270158. doi: 10.1371/journal.pone.0270158.r004

Author response to Decision Letter 1


26 May 2022

Response to the Editor:

1. Please address reviewer 2's minor points.

� We have done so, with responses below.

Response to Reviewer 1:

1. I greatly appreciate the author's responses and care in addressing them all in the manuscript or within the author replies.

� Thank you for your positive assessment of our revision.

Response to Reviewer 2:

1. Response rate was not addressed because collection methods did not allow for this data collection, this should be added to a limitations of the study

� We have added this as a limitation. See Lines 385-386: “We did not have information on response rate, as this was an online survey; we only had the number of completed responses.”

2. Table 2 is very busy with lots of data - I would move the headings to the center and highlight each subsection to make following the data easier for readers

� We have made this change.

3. Line 376 has inaccurate punctuation

� We have edited the punctuation, as follows: “Further, while the number of men was small compared to women (which did not allow for stratified analysis), we were able to calculate sex-adjusted estimates that can be used to guide future research focused on men specifically.”

Attachment

Submitted filename: PLoS One_response to reviewers 2.docx

Decision Letter 2

Emily W Harville

6 Jun 2022

Preconception risk factors and health care needs of pregnancy-planning women and men with a lifetime history or current mental illness: A nationwide survey

PONE-D-22-04073R2

Dear Dr. Dennis,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Emily W. Harville

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Emily W Harville

13 Jun 2022

PONE-D-22-04073R2

Preconception risk factors and health care needs of pregnancy-planning women and men with a lifetime history or current mental illness: A nationwide survey

Dear Dr. Dennis:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Emily W. Harville

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Dataset

    (XLS)

    Attachment

    Submitted filename: Formative Man4- mental health - Response- Mar 28 2022.docx

    Attachment

    Submitted filename: PLoS One_response to reviewers 2.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES